Your search returned 2 results.

Results
	1.	Safety and Efficacy of BIND-014, a Docetaxel Nanoparticle Targeting Prostate-Specific Membrane Antigen for Patients With Metastatic Castration-Resistant Prostate Cancer: A Phase 2 Clinical Trial. [electronic resource] by Autio, Karen A Dreicer, Robert Anderson, Justine Garcia, Jorge A Alva, Ajjai Hart, Lowell L Milowsky, Matthew I Posadas, Edwin M Ryan, Charles J Graf, Ryon P Dittamore, Ryan Schreiber, Nicole A Summa, Jason M Youssoufian, Hagop Morris, Michael J Scher, Howard I Producer: 20191009 In: JAMA oncology vol. 4 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Phase I Study of PSMA-Targeted Docetaxel-Containing Nanoparticle BIND-014 in Patients with Advanced Solid Tumors. [electronic resource] by Von Hoff, Daniel D Mita, Monica M Ramanathan, Ramesh K Weiss, Glen J Mita, Alain C LoRusso, Patricia M Burris, Howard A Hart, Lowell L Low, Susan C Parsons, Donald M Zale, Stephen E Summa, Jason M Youssoufian, Hagop Sachdev, Jasgit C Producer: 20180131 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 22 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search